For healthcare professionals. This information does not replace clinical judgement in the individual case; the current summary of product characteristics and the guidelines cited are authoritative.
Medically reviewed: Dr. med. univ. Daniel Pehböck, DESA, 01.11.2026
Glucagon (Pancreatic hormone (mobilises hepatic glycogen)) – indications: Severe hypoglycaemia without i.v. access – adults, Severe hypoglycaemia without i.v. access – children. Weight-based dosing in mg and ml in the app, with sources.
Indications
- Severe hypoglycaemia without i.v. access – adults
- Severe hypoglycaemia without i.v. access – children
Complete in the app
Weight-based doses in mg and ml, preparations, contraindications and notes – in the app, also offline.
Used in
Sources and guidelines
- Deutsche Diabetes Gesellschaft (DDG). S3-Leitlinie Therapie des Typ-1-Diabetes, Version 5, 2023. AWMF-Register-Nr. 057-013.
- Summaries of product characteristics of authorised products – product and section for each dose in the app.